Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 279-285 , December 2006

Attention-Deficit Hyperactivity Disorder

  • Mark L. Wolraich, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Mark L. Wolraich, MD, OU Child Study Center, 1100 NE 13th Street, Oklahoma City, OK 73117.

References 

  1. Perrin JM, Stein MT, Amler RW, et al. Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000;105:1158–1170
  2. Perrin JM, Stein MT, Amler RW, et al. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033–1044
  3. National Institutes of Health Consensus Development Conference Statement. Diagnosis and treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;39:182–188
  4. Swanson J, Castellanos F. Biological bases of ADHD—Neuroanatomy, genetics and pathophysiology. In:  Jensen P,  Cooper J editor. Attention Deficit Hyperactivity Disorder: State of the Science-Best Practices. Kingston, NJ: Civic Research Institute; 2002;
  5. Baumgaertel A, Wolraich ML. Practice guideline for the diagnosis and management of attention deficit hyperactivity disorder. Ambulatory Child Health. 1998;4:45–58
  6. Brown RT, Freeman WS, Perrin JM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics. 2001;107:e43
  7. Simpson D, Perry CM. Atomoxetine. Pediatric Drugs. 2003;5:407–415
  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (ed 4) (Text Revision). Washington, DC: American Psychiatric Association; 2000;
  9. Wolraich ML, Lambert W, Worley K, et al. Psychometric properties of the Vanderbilt ADHD Diagnostic Parent Rating Scale. J Pediatr Psychol. 2003;28:559–568
  10. Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles (Research Center for Children, Youth, & Families). Burlington, VT: University of Vermont; 2001;
  11. Wolraich ML, Feurer I, Hannah JN, et al. Obtaining systematic teacher report of disruptive behavior disorders utilizing DSM-IV. J Abnorm Child Psychol. 1998;26:141–152
  12. Touwen B, Kalverboer AF. Neurologic and behavioral assessment of children with minimal brain dysfunction. Semin Psychiatry. 1973;5:79–94
  13. Maloney M, Glasser A. An evaluation of the clinical utility of the Draw-a-Person Test. J Clin Psychol. 1982;38:183–190
  14. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775–1779
  15. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: The chronic care model, part 2. JAMA. 2002;288:1909–1914
  16. Greenhill LL, Halperin JM, Abikoff H. Stimulant Medications. J Am Acad Adolesc Psychiatry. 1999;38:503–512
  17. Pelham W, Wheeler T, Chronis A. Empirically supported psychological treatments for attention deficit hyperactivity disorder. J Clin Child Psychol. 1998;27:190–205
  18. Greenhill LL. Attention-deficit hyperactivity disorder: The stimulants. Child Adolesc Psychiatr Clin N Am. 1995;4:123–168
  19. Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22:60–73
  20. Allen A, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005;65:1941–1949

PII: S1071-9091(06)00131-8

doi: 10.1016/j.spen.2006.09.008

Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 279-285 , December 2006

Article Tools